Search dm+d | This AMP cannot be matched against our prescribing data.
Description | COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) |
BNF code | 1404000ATBBAAAA |
Virtual Medicinal Product | Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials |
Name | COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials |
Abbreviated name | COVID-19 Vaccine Vaxzevria 0.5ml inj multidose vials |
Date of name applicability | 10 May 2022 |
Previous name | COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials |
Supplier | AstraZeneca UK Ltd |
Current licensing authority | Medicines - MHRA/EMA |
Previous licensing authority | None |
Reason for change of licensing authority | Licence Granted |
Date of change of licensing authority | 5 Jan 2021 |
EMA additional monitoring | ✓ |
Parallel import | ✗ |
Restrictions on availability | Restricted Availability |
Licensed Route | |
---|---|
Licenced route | Intramuscular |
Actual Medicinal Product Packs | |
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) 100 dose 10 x 10 dose vials | |
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) 10 dose | |
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) 80 dose 10 x 8 dose vials | |
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) 8 dose |
dm+d data retrieved from TRUD: release NHSBSA_6.3.0_20240624000001, imported on 24th June 2024 at 05:06:11.